This study is being done to find out if medicines that affect a neurotransmitter (chemical
messenger) in the brain called adenosine improve behavioral problems that are related to drug
abuse. Another purpose of the study is to find out how genes related to adenosine change how
people respond to these medicines. More information about how these medicines change
behaviors may be helpful to come up with new treatments for drug abuse.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborators:
National Institute on Drug Abuse (NIDA) The University of Texas Health Science Center, Houston